Lantheus Holdings, Inc. is the parent company of Lantheus Medical Imaging, Inc. (“Lantheus”), which is a global leader in the development, distribution and commercialization of innovative diagnostic image agents and products. For 60 years, Lantheus has been dedicated to creating and providing pioneering medical imaging solutions to improve the treatment of human disease. Our agents and products assist physicians in the diagnosis of conditions affecting the heart, brain, lungs and other organs using echocardiography and nuclear imaging technologies.
NASDAQ | LNTH (Common Stock)
$8.28 + 0.39
Data provided by Nasdaq. Minimum 15 minutes delayed.
|There are currently no events scheduled.|
Receive E-mail Alerts
|Sign up to receive e-mail alerts whenever Lantheus Holdings, Inc. posts new information to the site. Just enter your e-mail address and click Submit.|